Rare Disease
Rare Disease Biotech Announces ‘Hugely Significant’ Milestone with Selection of Candidate Drug
SynaptixBio
PR-06-25-NI-02Jun 10, 2025
RNA
Beyond mRNA Vaccines: The Expanding World of RNA-Based Therapeutics
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-24Mar 21, 2025
Gene Tools
Unlocking New Possibilities in Research, Therapeutics, and Beyond with Morpholino Antisense Oligos
David Alvaro, Ph.D.; Jon Moulton, Ph.D.
Pharma's Almanac
PAO-01-23-CL-05Feb 01, 2023
Column: New Drug Watch
Potential Applications for Antisense Oligonucleotide Therapies Continue to Expand
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-10-022-NI-06Oct 11, 2022